RxDoctor Payments Data

Sandra Zawadka, DPM

Foot Surgery · East Patchogue, NYNPI 1164050704

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,459 of the $3,117 with a category attached, or 78.9%. 13 manufacturers reported payments, led by Stryker at 29.1% of the total. Reporting peaked in 2023 at $2,113 and has fallen 83.7% since, to $344 in 2025.

$3,117in general payments, 2019–2025

Across 34 payments — averaging $91.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$907
  • Integra Lifesciences Corporation$795
  • Kerecis Limited$546
  • Tactile Systems Technology Inc$295
  • Smith+Nephew$206
  • Treace Medical Concepts, Inc.$193
  • plus $174 from 7 others

What the payments were for

  • Travel & lodging$65821%
  • Food & beverage$2,45979%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,117 in reported general payments places this provider in the 80th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$175,919
Medicare patients
467
Services billed
1,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole302$7,715
Ammonium Lactate21$262
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$209
Clotrimazole11$130
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$92
Methylprednisolone19$91
Meloxicam38$77

Paid to pharmacies, not to this prescriber.

Other foot surgery in East Patchogue

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →